share_log

Mustang Bio Analyst Ratings

マスタングバイオアナリストの評価

Benzinga ·  2023/08/24 12:00
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
08/24/2023 516.44% Cantor Fitzgerald → $18 Reiterates Overweight → Overweight
08/16/2023 756.16% HC Wainwright & Co. → $25 Reiterates Buy → Buy
08/15/2023 447.95% BTIG $20 → $16 Maintains Buy
08/15/2023 756.16% HC Wainwright & Co. → $25 Reiterates Buy → Buy
06/16/2023 584.93% BTIG $4 → $20 Maintains Buy
06/16/2023 756.16% HC Wainwright & Co. → $25 Reiterates Buy → Buy
05/15/2023 139.73% HC Wainwright & Co. → $7 Reiterates Buy → Buy
03/30/2023 139.73% HC Wainwright & Co. → $7 Reiterates → Buy
11/16/2022 36.99% BTIG $8 → $4 Maintains Buy
01/24/2022 105.48% B. Riley Securities $13 → $6 Maintains Buy
05/18/2021 276.71% BTIG → $11 Initiates Coverage On → Buy
12/23/2020 345.21% B. Riley FBR → $13 Reinstates → Buy
10/02/2020 208.22% B. Riley Securities → $9 Initiates Coverage On → Buy
05/12/2020 345.21% Oppenheimer $15 → $13 Maintains Outperform
11/20/2019 139.73% Cantor Fitzgerald → $7 Assumes → Overweight
08/13/2019 HC Wainwright & Co. Initiates Coverage On → Buy
08/13/2019 139.73% HC Wainwright & Co. → $7 Initiates Coverage On → Buy
06/21/2019 139.73% Cantor Fitzgerald → $7 Initiates Coverage On → Overweight

What is the target price for Mustang Bio (MBIO)?

The latest price target for Mustang Bio (NASDAQ: MBIO) was reported by Cantor Fitzgerald on August 24, 2023. The analyst firm set a price target for $18.00 expecting MBIO to rise to within 12 months (a possible 516.44% upside). 9 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Mustang Bio (MBIO)?

The latest analyst rating for Mustang Bio (NASDAQ: MBIO) was provided by Cantor Fitzgerald, and Mustang Bio reiterated their overweight rating.

When is the next analyst rating going to be posted or updated for Mustang Bio (MBIO)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Mustang Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Mustang Bio was filed on August 24, 2023 so you should expect the next rating to be made available sometime around August 24, 2024.

Is the Analyst Rating Mustang Bio (MBIO) correct?

While ratings are subjective and will change, the latest Mustang Bio (MBIO) rating was a reiterated with a price target of $0.00 to $18.00. The current price Mustang Bio (MBIO) is trading at is $2.92, which is within the analyst's predicted range.

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする